Dottikon ES Holding AG Logo

Dottikon ES Holding AG

Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.

DESN | SW

Overview

Corporate Details

ISIN(s):
CH0582581713
LEI:
50670064H782SV8G2Z44
Country:
Switzerland
Address:
Hembrunnstrasse 17, 5605 Dottikon
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dottikon ES Holding AG specializes in the exclusive synthesis of fine chemicals, manufacturing high-quality performance chemicals, intermediates, and active pharmaceutical ingredients (APIs). Serving the global chemical, biotech, and pharmaceutical industries, the company's core expertise lies in hazardous reactions, leveraging over 110 years of experience. Dottikon provides comprehensive services from research and development, including route-finding and process development, to multi-ton cGMP-compliant production. All operations are managed from a single strategic site, with quality management systems approved by the FDA and Swissmedic.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dottikon ES Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Dottikon ES Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-06-18 N/A Executive member Sell None 19,500,000.00 CHF
2023-07-24 N/A Executive member Sell None 72,600.00 CHF
2023-06-15 N/A Executive member Sell None 85,872,280.00 CHF
2023-06-15 N/A Non-Executive member Buy None 26,000.00 CHF
2023-06-01 N/A Non-Executive member Buy None 30,240.00 CHF

Peer Companies

Company Country Ticker View
Astena Holdings Co., Ltd. Logo
Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.
Japan 8095
AstraZeneca PLC Logo
Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.
United Kingdom AZN
Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.
South Korea 355690
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland BANB
Basilea Pharmaceutica AG Logo
Develops & commercializes anti-infectives for severe bacterial & fungal infections.
Switzerland BSLN
Bavarian Nordic Logo
A biotech firm developing and manufacturing life-saving vaccines for travel and public health.
Denmark BAVA
Bayer AG Logo
A life science firm providing pharmaceuticals, consumer health, and crop science solutions.
Germany BAY
Benchmark Holdings Plc Logo
Aquaculture biotech providing nutrition and health solutions for sustainable farming.
United Kingdom BMK
BIFIDO. Co. Ltd Logo
Biotech firm specializing in microbiome R&D for functional foods and cosmeceuticals.
South Korea 238200
BioArctic Logo
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
Sweden BIOA

Talk to a Data Expert

Have a question? We'll get back to you promptly.